|
FDMT 4D Molecular Therapeutics Inc 1650648 |
| Balance Sheet |
|
Current Assets
|
$382,957,000.00 |
|
Assets
|
$492,615,000.00 |
|
Current Liabilities
|
$47,673,000.00 |
|
Liabilities
|
$84,956,000.00 |
|
Equity
|
$407,659,000.00 |
|
Shares Out
|
55214097.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-138,124,000.00 |
|
Investing Cash Flow
|
$94,432,000.00 |
| Market Analysis |
Market Cap
|
$888,946,961.70 |
|
Price
|
$16.10 |
|
BVPS
|
7.38 |
|
PB
|
2.18 |
|
EPS
|
-1.04 |
|
PS
|
58.78 |
|
FCF
|
$-138,179,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
-2.42 |
|
|
2026-05-07 |
-1.01 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.98 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-1.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FDMT documents filed with the SEC.
FDMT Filings
Clear
